Why Did Plus Therapeutics (PSTV) Soar 12.24%?

Plus Therapeutics, Inc. (PSTV) experienced a significant surge in its stock price, rising 12.24% in pre-market trading on July 24, 2025. This substantial increase comes after a period of volatility and positive momentum for the company.

In recent weeks, Plus Therapeutics has shown strong performance, with its stock price gaining 15.29% on the last trading day, July 23, 2025. The stock has risen for three consecutive days, indicating a bullish trend. The company's stock has also seen increased trading volume, which is a positive technical sign. Analysts have noted that the stock holds buy signals from both short and long-term moving averages, suggesting a positive forecast. Additionally, the stock has support levels at $0.385 and $0.327, which could act as a buffer against potential downturns.

Despite the recent gains, there are concerns about the stock's overbought status on the RSI14 indicator, which suggests a potential correction in the near future. However, the company's strong performance and positive signals from technical indicators have led analysts to upgrade their recommendation for Plus Therapeutics from a "Buy" to a "Strong Buy" candidate. The predicted fair opening price for July 24, 2025, is $0.484, indicating a slight increase from the previous closing price.